The opening of the tender is on the right! The third batch of band volume procurement, 8 charts all-round analysis.

On August 19th, the third batch of national volume procurement will be formally tendered.
the author has published the "third batch of volume procurement, 6 chart depth analysis", is to undertake the above and then around the third batch of volume procurement to do further analysis.
1, the overall overview of the volume of the report after the "4 plus 7", "4 plus 7" expansion and the second batch of national volume procurement in-depth exploration, the operation experience is increasingly rich, belt volume procurement has entered the normal, institutionalized and standardized stage.
The third batch of belt procurement is a sign of the beginning of normalization, with the vast number of patients and medical personnel on the selection of varieties of recognition of the continuous improvement, as well as the number of varieties included in the collection and coverage of the expansion, the volume of reports also increased from "4 plus 7" 1.64 billion pieces / grain / bag / branch to the third batch of 200.05 billion pieces / bags / branch (Figure 1), an increase of more than 11 times.
in the face of such a huge market temptation and the determination of the authorities to take full action, as well as the balance of retention caused by the embarrassment of unsealed varieties, the relevant enterprises will actively participate, so the auction will still be extremely fierce.
Procurement volume with the increasing volume, its corresponding procurement volume also increased, from "4 plus 7" of 1.9 billion yuan, "4 plus 7" expansion of 3.5 billion yuan, the second batch of 8.8 billion yuan, has been increased to the third batch of 22.65 billion yuan, compared with the original "4 plus 7" also increased more than 11 times (Figure 2).
if the impact of the "4 plus 7" as a pilot on pharmaceutical companies is still limited to the spirit, from the third batch, with volume procurement will become an unavoidable mainstream event in the pharmaceutical industry.
2, the third batch of variety analysis volume procurement involving a total of 56 varieties, 81 specifications, the total volume of up to 20,005 million pieces / grain / bag / branch.
Of these, the largest reported volume was metformin oral normal release agent type, up to 4.66 billion tablets, accounting for 23.3% of the total reported volume; The total number of reports of omeprazole and pythons is as high as 10.58 billion tablets, accounting for more than half of the total volume (53%) (Figure 3), these varieties will also become the main object of fierce competition among pharmaceutical companies, especially metformin oral regular release agent type, as many as 28 enterprises qualified to declare, and up to 8 can be selected, the other 20 must be out, the intensity of competition can be imagined.
procurement volume and procurement volume will stimulate the degree of competition of enterprises, the third batch of total procurement volume of 22.65 billion yuan.
of these, the highest amount of procurement was moxie sodium chloride injections, amounting to 1.76 billion yuan, accounting for 7.8% of the total procurement volume, and the smallest procurement volume was Ramifeddin, only 170,000 yuan, accounting for only 7.5 per 10,000.
In addition, the first seven varieties (moxisacin, tigrillo, metformin oral recurring agent type, non-netrosamine 5mg, methyl cobaltamine, amino glucose, pyvastatin) accounted for 39.5 per cent of total procurement, totalling $8.94 billion (figure 4).
3, provincial analysis in addition to the varieties between the volume and procurement of large differences, there are also great differences between different regions.
of the country's 31 provinces, Guangdong Province had the largest volume, with 1,944 million tablets/grains/bags/pockets, accounting for 9.7% of the total reported volume, while Tibet accounted for the smallest volume, with only 27.16 million tablets/grains/bags/pockets. 1 per cent, mainly due to the fact that its total population also accounts for only 2.5 per cent of the country's population, while the top five provinces (Guangdong, Zhejiang, Shandong, Jiangsu and Henan) account for 42 per cent of the country's reported volume, totalling 8.4 billion tablets/grains/bags/supports (Figure 5).
Guangdong's reported volume is the largest, and some of its varieties of reported large volume, such as Guangdongacid Westina non-film reported volume accounted for nearly 70% of the national volume.
Although the highest effective declaration price of this collection is not low, and the continuation of the second batch of "'unit 20 available price' s 0.1000 yuan" can be selected provisions to prevent the spread of the atmosphere of low price is taken, but based on the "first-in-position enterprise priority in supply" Regional selection of a region" provisions, such as Guangdong, such as the province of oversized reporting still brings a special temptation to enterprises, enterprises have not only satisfied with winning the bid, but try to use the lowest price to fight the "supply area to choose one region" priority, so as to obtain the largest volume of provinces sales rights.
Previously in the second batch of volume procurement of a total of 100 selected varieties, the price war is also very fierce, there are 30 varieties of minimum specification price is less than 0.1 yuan, of which 17 minimum specification price is less than 6 cents (Figure 6).
The largest amount of procurement is still in Guangdong Province, amounting to 2,594 million yuan, accounting for 11.46 percent of the country, the smallest is Qinghai Province, only 46.17 million yuan, accounting for 2 percent of the country, the top six provinces (Guangdong, Zhejiang, Jiangsu, Shanghai, Shandong, Beijing) accounted for just half of the country, a total of 11.37 billion yuan (Figure 7).
4, the first three reduction in price reduction is not the only measure of the effectiveness of the purchase with volume, but it is the most intuitive indicator, in addition to the average price reduction, the largest decline in a single variety also attracted people's attention.
review of the decline in the previous three national volume procurement, can also provide a reference for predicting the decline in this collection.
the first 3 harvests, the average decline basically maintained at a level of just over 50%, the highest decline of a single variety is more than 90%, the lowest decline of about 10%.
For example, the average decrease of "4 plus 7" was 52%, the largest decrease was in the fuma acid tynofove ester dipyridine tablets, as high as 96.25%, the smallest decrease was 6.85%, the second batch of belt procurement average decline of 53%, the largest decrease is 93% of the hydrochloric acid zocitridine tablets, the smallest reduction is 11% of the fluconazole capsules.
with volume procurement has become a breakthrough in the new medical reform, in the face of the normalization of belt procurement and the trend of full coverage, pharmaceutical companies have been unable to avoid, only positive response is the best policy.
, however, stay in the sales level of the response is about to be poor donkey skills, enterprises should be from the breed project, enterprise strategy and other more front-end and macro-level transformation and upgrading is the best policy.
and do a good job on August 20th to carry out the third batch of volume purchase quotation is the most urgent task.
.